ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM)

Clinical trials for ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM) explained in plain language.

Never miss a new study

Get alerted when new ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM) trials appear

Sign up with your email to follow new studies for ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare blood cancer: targeted drug trial opens

Disease control Recruiting now

This study tests a new drug called CGT9486 (bezuclastinib) in people with advanced systemic mastocytosis, a rare and serious blood disorder. The drug aims to control the disease by targeting a specific genetic mutation. About 140 adults with aggressive forms of the condition will…

Matched conditions: ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM)

Phase: PHASE2 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control

Last updated May 17, 2026 05:17 UTC

ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM)

Get alerted when new ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM) trials appear

New hope for rare blood cancer: targeted drug trial opens